ADARx Pharmaceuticals, Inc. (ADRX) has 5 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 28, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 28, 2026 filed Sept. 24, 2026 | Ackles Robert William Chief People Officer | $0 | 85,346 | 0% | No | |
|
|
||||||
| Sept. 28, 2026 filed Sept. 24, 2026 | Li Zhen President and CEO | $0 | 1,024,152 | 0% | No | |
|
|
||||||
| Sept. 28, 2026 filed Sept. 24, 2026 | MacLeod Alan Robert Chief Scientific Officer | $0 | 170,692 | 0% | No | |
|
|
||||||
| Sept. 28, 2026 filed Sept. 24, 2026 | Zhu Rui (NMN) Chief Technology Officer | $0 | 512,076 | 0% | No | |
|
|
||||||
| Sept. 28, 2026 filed Sept. 24, 2026 | Fisk Ryan CFO and CBO | $0 | 170,692 | 0% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free